Stock screenerAll disclosures →
EDGAR →
ABCL
Conviction 100HealthcareScan · Mon, Aug 10, 2026ABCL$9.34+34.70%
ResistanceSupportVol 14Insider buyVol MA14 7.05M
May 11May 28Jun 16Jul 6Jul 23Aug 10
WSB mentions · 24h changelatest +300.00%· 4 mentions
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price9.34
Change+34.70%
Gap+26.62%
Rel volume6.81×
Avg volume6.5M
Avg $ vol44.59M
SMA 206.13
SMA 506.26
SMA 2004.51
Price vs 50+49.10%
Price vs 200+106.89%
MA stackbullish
50/200 cross—
Supertrendup · 6.96
RSI (14)77
MACD hist0.29
MACD crossbull · 2d
Stoch %K / %D87 / 94
ADX (14)23
+DI / −DI50 / 11
RSI divergence—
MACD divergence—
ATR %+7.44%
ADR %8.04%
52w high9.34
52w low2.78
From 52w high+0.00%
Above 52w low+235.79%
New 52w highYes
SqueezeOff
Bollinger width57.73%
%B1.41
Donchian pos86.58%
Donchian high10.01
Donchian low4.98
AVWAP (52w high)9.28
vs AVWAP high+0.65%
AVWAP (52w low)5.30
vs AVWAP low+76.24%
OBV trendUp
Chaikin MF (20)0.06
Today vs 20d6.81×
Avg vol (14d)7.05M
Avg vol (20d)6.5M
Avg $ vol (20d)44.59M
Market cap2.86B
RS 3m (vs SPY)+38.08%
RS 6m (vs SPY)+135.17%
RS line new highNo
Trend template8/8
Technical rank97.6
1 week+60.12%
1 month+37.28%
3 months+78.15%
6 months+195.41%
1 year+120.17%
YTD+172.16%
P/E-19.55
P/B3.19
P/S38.10
P/FCF-16.44
EPS-0.4900
Div yield—
ROE-16.34%
ROA-11.20%
Debt/Eq0.00
Current12.77
EV/EBITDA—
Gross margin—
Net margin-194.88%
Rev growth160.56%
EPS growth10.10%
Price target13.00
Target upside39.26%
Analyst ratingBuy
Institutional42.55%
Ent. value2.74B
Revenue4.05M
Net income-55.43M
Gross profit—
Free cash flow-174.07M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out305.38M
Employees562
ListedFri, Dec 11, 2020
Free float208.73M
Float %69.7%
Short interest45.11M
Days to cover7.0d
Short volume53.0%
Squeeze score89 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.18 vs −$0.17
Last surprise-5.9% miss
Setup gradeA+
Conviction100 / 100
Pattern quality—
Tech rank97.6 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance8.43
Support5.00
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in ABCL
No recent disclosed trades by Congress in ABCL. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in ABCL · 7 buys · 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Sandor Victor Director · Share option (right to buy) · 2026-07-01 | Grant | 152.21K | — | 2026-07-01 | 2026-07-06 |
Seely Lynn Director · Share option (right to buy) · 2026-07-01 | Grant | 152.21K | — | 2026-07-01 | 2026-07-06 |
Hayden Michael R Director · Share option (right to buy) · 2026-06-11 | Grant | 111.7K | — | 2026-06-11 | 2026-06-12 |
Quake Stephen Director · Share option (right to buy) · 2026-06-11 | Grant | 111.7K | — | 2026-06-11 | 2026-06-12 |
Montalbano John S. Director · Share option (right to buy) · 2026-06-11 | Grant | 111.7K | — | 2026-06-11 | 2026-06-12 |
Booth Andrew Chief Financial Officer · Common Shares · 2026-06-03 | Other | — | — | 2026-06-03 | 2026-06-03 |
Booth Andrew Chief Financial Officer · Share option (right to buy) · 2026-06-03 | Exercise | 250K | $0 | 2026-06-03 | 2026-06-03 |
Booth Andrew Chief Financial Officer · Common Shares · 2026-06-03 | Exercise | 250K | $48K | 2026-06-03 | 2026-06-03 |
Montalbano John S. Director · Common Shares · 2026-05-14 | Other | — | — | 2026-05-14 | 2026-05-18 |
Montalbano John S. Director · Common Shares · 2026-05-14 | Buy | 20K | $95K | 2026-05-14 | 2026-05-18 |
SEC filings
EDGAR filings in ABCL · 8 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.